NCT05275478 2025-11-14Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTango Therapeutics, Inc.Phase 1/2 Active not recruiting192 enrolled
NCT05563272 2025-07-10STARBURSTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 2 Terminated11 enrolled
NCT02611024 2025-07-09Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsPharmaMarPhase 1/2 Completed316 enrolled